Abstract
The incidence rate of cervical cancer in Indonesia remains high; however, it can be prevented through early detection. The study aimed to assess the effectiveness of the DEDIKASI mobile application, a continuation of the Early Warning System (EWS) cancer application for cervical cancer risk assessment in women of reproductive age. Employed a quasi-experimental design with a nonequivalent group posttest-only approach, the research included 388 participants chosen through random sampling. The EWS Application group showed a majority categorized as "Very Suspect" (52.6%), while the DEDIKASI group had the majority in the "High Risk" category (40.7%). ISO 25010 testing revealed an excellent overall score of 92% for the DEDIKASI application, indicating strong functional suitability and usability. The t-test results (p-value = 0.000) indicated that the DEDIKASI application was more effective than the EWS Cervical Ca application in assessing cervical cancer risk. The findings underscore the potential of the DEDIKASI mobile application for improving early detection and risk assessment of cervical cancer in women of childbearing age, offering a valuable tool to address the high incidence rate of cervical cancer in Indonesia.
Subject
Industrial and Manufacturing Engineering,Environmental Engineering
Reference48 articles.
1. Budi HS, Younus LA, Lafta MH, et al. The role of miR-128 in cancer development, prevention, drug resistance, and immunotherapy. Front Oncol 2023;12:1067974.
2. Suleman S, Fitriana S, Cahyati E. Aplikasi Sistem Pakar Deteksi Dini Kanker Serviks Berbasis Android. Indones J Comput Inf Technol 2019;4(1).
3. WHO. Cervical cancer Indonesia 2021 country profile. 2021. Available from: https://www.who.int/publications/m/item/cervical-cancer-idn-country-profile-2021
4. Kristina SA, Endarti D, Aditama H. Prediction of Productivity Costs Related to Cervical Cancer Mortality in Indonesia 2018. Malays J Med Sci 2022;29:138–44.
5. Fitzmaurice C, Abate D, Abbasi N, et al. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-Adjusted life-years for 29 cancer groups, 1990 to 2017: A systematic analysis for the global burden of disease study. JAMA Oncol 2019;5:1749–68.